|
SE0102299D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
|
US7087631B2
(en)
*
|
2002-07-18 |
2006-08-08 |
Inotek Pharmaceuticals Corporation |
Aryltetrazole compounds, and compositions thereof
|
|
US7078423B2
(en)
*
|
2002-07-18 |
2006-07-18 |
Inotek Pharmaceuticals Corporation |
5-Aryltetrazole compounds, compositions thereof, and uses therefor
|
|
NZ539013A
(en)
*
|
2002-10-03 |
2007-05-31 |
Novartis Ag |
Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
|
|
GB0226931D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
MY141521A
(en)
|
2002-12-12 |
2010-05-14 |
Hoffmann La Roche |
5-substituted-six-membered heteroaromatic glucokinase activators
|
|
WO2004063194A1
(en)
*
|
2003-01-06 |
2004-07-29 |
Eli Lilly And Company |
Heteroaryl compounds
|
|
WO2004072066A1
(en)
*
|
2003-02-11 |
2004-08-26 |
Prosidion Limited |
Tri(cyclo) substituted amide glucokinase activator compounds
|
|
PL378117A1
(pl)
*
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
|
CA2561157A1
(en)
*
|
2004-04-02 |
2005-10-13 |
Novartis Ag |
Thiazolopyridine derivatives, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions
|
|
RU2412192C2
(ru)
*
|
2004-04-02 |
2011-02-20 |
Новартис Аг |
Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2
|
|
JP4651714B2
(ja)
|
2005-07-09 |
2011-03-16 |
アストラゼネカ アクチボラグ |
糖尿病の治療においてｇｌｋ活性化剤として使用するためのヘテロアリールベンズアミド誘導体
|
|
US7514439B2
(en)
|
2005-07-11 |
2009-04-07 |
Mitsubishi Tanabe Pharma Corporation |
Oxime derivative and preparations thereof
|
|
AU2006285834A1
(en)
|
2005-08-31 |
2007-03-08 |
Astellas Pharma Inc. |
Thiazole derivative
|
|
JP2007063225A
(ja)
*
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
WO2007039177A2
(en)
|
2005-09-29 |
2007-04-12 |
Sanofi-Aventis |
Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
|
|
GT200600429A
(es)
*
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
|
GT200600428A
(es)
*
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
|
CA2626475A1
(en)
*
|
2005-11-03 |
2007-05-10 |
Prosidion Limited |
Tricyclo substituted amides
|
|
JP2009515997A
(ja)
*
|
2005-11-18 |
2009-04-16 |
タケダ サン ディエゴ インコーポレイテッド |
グルコキナーゼ活性剤
|
|
WO2007069684A1
(ja)
*
|
2005-12-15 |
2007-06-21 |
Nihon Nohyaku Co., Ltd. |
フタルアミド誘導体及び農園芸用殺虫剤並びにその使用方法
|
|
US8034822B2
(en)
|
2006-03-08 |
2011-10-11 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
PE20080251A1
(es)
|
2006-05-04 |
2008-04-25 |
Boehringer Ingelheim Int |
Usos de inhibidores de dpp iv
|
|
EP2049518B1
(en)
*
|
2006-05-31 |
2011-08-31 |
Takeda San Diego, Inc. |
Indazole and isoindole derivatives as glucokinase activating agents.
|
|
US7910747B2
(en)
*
|
2006-07-06 |
2011-03-22 |
Bristol-Myers Squibb Company |
Phosphonate and phosphinate pyrazolylamide glucokinase activators
|
|
US7902248B2
(en)
|
2006-12-14 |
2011-03-08 |
Hoffmann-La Roche Inc. |
Oxime glucokinase activators
|
|
WO2008079787A2
(en)
|
2006-12-20 |
2008-07-03 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
TW200831081A
(en)
*
|
2006-12-25 |
2008-08-01 |
Kyorin Seiyaku Kk |
Glucokinase activator
|
|
EP2105435A4
(en)
*
|
2007-01-10 |
2011-06-15 |
Mitsubishi Tanabe Pharma Corp |
Hydrazone derivative
|
|
EP2116533B1
(en)
*
|
2007-03-07 |
2013-07-10 |
Kyorin Pharmaceutical Co., Ltd. |
Glucokinase activator
|
|
WO2008116107A2
(en)
*
|
2007-03-21 |
2008-09-25 |
Takeda San Diego, Inc. |
Piperazine derivatives as glucokinase activators
|
|
EP2195304B1
(en)
*
|
2007-10-08 |
2014-01-08 |
Advinus Therapeutics Private Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal applications
|
|
AR070107A1
(es)
*
|
2008-01-15 |
2010-03-17 |
Lilly Co Eli |
R-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida en forma cristalina, composicion farmaceutica que la comprende y su uso para la manufactura de un medicamento util para la prevencion o tratamiento de hiperglicemia
|
|
RU2010134411A
(ru)
*
|
2008-01-18 |
2012-02-27 |
Астеллас Фарма Инк. (Jp) |
Фенилацетамидное производное
|
|
NZ588462A
(en)
|
2008-04-28 |
2012-07-27 |
Kyorin Seiyaku Kk |
Cyclopentylacrylic acid amide derivative
|
|
CN105176930B
(zh)
|
2010-03-31 |
2021-05-04 |
斯克里普斯研究所 |
重编程细胞
|